logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Methods for estimating the occurrence of polypharmacy by means of a prescription database.

    Article - En anglais

    Objective 

    Concurrent use of multiple drugs (polypharmacy, PP) may cause health risks such as adverse drug reactions, medication errors and poor compliance.

    The objective of this study, based on data from a prescription database, was to evaluate estimators of PP in the general population.

    Methods 

    Data were retrieved from Odense Pharmacoepidemiological Database (OPED) and consisted of all prescriptions in 1994 from a 10% random sample of drug users (n=26977) in the county of Funen, Denmark.

    For each prescription, the period of consumption was calculated by setting the duration of treatment to equal the amount of drug purchased, as measured in defined daily doses (DDD), thereby assuming a daily intake of one DDD.

    PP was defined as overlapping periods of consumption for different drugs.

    A Venn diagram was used to illustrate and compare this estimator of PP with two other indicators of multiple-drug use : the number of drugs purchased in 3 months and the mean number of drugs used in 1 year.

    A receiver operating curve (ROC) was used to evaluate the possibility of predicting episodes of PP from the number of drugs purchased in 3 months.

    Results 

    The proposed estimator of PP was robust towards changes in DDD.

    On an average day in 1994, the prevalence of PP was 9.9% and the standard deviation (SD) between days was 0.3%. Two to four drugs (minor PP) were used by 8.7% of the population (SD, 0.2%) and five or more drugs (major PP) by 1.2% (SD, 0.1%). (...)

    Mots-clés Pascal : Epidémiologie, Association médicamenteuse, Interaction médicamenteuse, Toxicité, Estimation, Base donnée, Prescription, Etude comparative, Homme

    Mots-clés Pascal anglais : Epidemiology, Drug combination, Drug interaction, Toxicity, Estimation, Database, Prescription, Comparative study, Human

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0522881

    Code Inist : 002B30A01C. Création : 13/02/1998.